Supplementary Table 1a.xlsx: Temporal Variations of Country specific mutational profile of SARS-CoV-2: Effect on Vaccine Efficacy

Supplementary Table 1a: All frequently mutated amino acid residues that have encountered substitutions in 2% or more of all SARS-CoV-2 isolates, in at least one country, before May (Group B). The frequencies above 2% have been highlighted in ‘red’